Chuanlu Jiang

3.4k total citations
48 papers, 1.6k citations indexed

About

Chuanlu Jiang is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Chuanlu Jiang has authored 48 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 21 papers in Cancer Research and 18 papers in Genetics. Recurrent topics in Chuanlu Jiang's work include Glioma Diagnosis and Treatment (16 papers), MicroRNA in disease regulation (14 papers) and Cancer-related molecular mechanisms research (9 papers). Chuanlu Jiang is often cited by papers focused on Glioma Diagnosis and Treatment (16 papers), MicroRNA in disease regulation (14 papers) and Cancer-related molecular mechanisms research (9 papers). Chuanlu Jiang collaborates with scholars based in China, Russia and United States. Chuanlu Jiang's co-authors include Xiangqi Meng, Tao Jiang, Wenzhong Du, Jinquan Cai, Lingchao Chen, Yongli Li, Feng Yan, Pei Yang, Jinquan Cai and Dongbo Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Chuanlu Jiang

48 papers receiving 1.6k citations

Peers

Chuanlu Jiang
Abhik Ray‐Chaudhury United States
W. Shawn Carbonell United States
Beth Coyle United Kingdom
Haipeng Xue United States
Jong Wook Chang South Korea
Lei Cao China
Shin-Hyuk Kang South Korea
Chuanlu Jiang
Citations per year, relative to Chuanlu Jiang Chuanlu Jiang (= 1×) peers Zhiguo Lin

Countries citing papers authored by Chuanlu Jiang

Since Specialization
Citations

This map shows the geographic impact of Chuanlu Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanlu Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanlu Jiang more than expected).

Fields of papers citing papers by Chuanlu Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanlu Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanlu Jiang. The network helps show where Chuanlu Jiang may publish in the future.

Co-authorship network of co-authors of Chuanlu Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanlu Jiang. A scholar is included among the top collaborators of Chuanlu Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanlu Jiang. Chuanlu Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Yin, et al.. (2025). Integrating deep learning and radiomics for preoperative glioma grading using multi-center MRI data. Scientific Reports. 15(1). 36756–36756. 1 indexed citations
2.
Wang, Xinyu, Hao Chen, Dan Song, et al.. (2023). Using integrated analysis from multicentre studies to identify RNA methylation-related lncRNA risk stratification systems for glioma. Cancer Cell International. 23(1). 6 indexed citations
3.
Meng, Xiangqi, Zhenyu Wang, Xinyu Wang, et al.. (2021). A Voxel-Based Radiographic Analysis Reveals the Biological Character of Proneural-Mesenchymal Transition in Glioblastoma. Frontiers in Oncology. 11. 595259–595259. 4 indexed citations
4.
Han, Bo, Xiangqi Meng, Pengfei Wu, et al.. (2020). ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma. Theranostics. 10(7). 3351–3365. 84 indexed citations
6.
Liang, Xia, et al.. (2019). White Matter Hyperintensities Relate to Basal Ganglia Functional Connectivity and Memory Performance in aMCI and SVMCI. Frontiers in Neuroscience. 13. 1204–1204. 14 indexed citations
7.
Sun, Jiahang, Dawei Meng, Yang Xu, et al.. (2017). Antagomirs Targeting MicroRNA-134 Increase Limk1 Levels After Experimental Seizures in Vitro and in Vivo. Cellular Physiology and Biochemistry. 43(2). 636–643. 10 indexed citations
8.
Liu, Daming, Hongjun Wang, Bo Han, et al.. (2016). CAMKK2, Regulated by Promoter Methylation, is a Prognostic Marker in Diffuse Gliomas. CNS Neuroscience & Therapeutics. 22(6). 518–524. 16 indexed citations
9.
Yang, Hui, Yu Tian, Qing Xie, et al.. (2016). SOX7 is associated with the suppression of human glioma by HMG-box dependent regulation of Wnt/β-catenin signaling. Cancer Letters. 375(1). 100–107. 30 indexed citations
10.
Zhang, Haitao, Ping Zhang, Yi Gao, et al.. (2016). Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs. Molecular Medicine Reports. 15(1). 57–64. 82 indexed citations
11.
Yang, Pei, Jinquan Cai, Wei Yan, et al.. (2016). Classification based on mutations ofTERTpromoter andIDHcharacterizes subtypes in grade II/III gliomas. Neuro-Oncology. 18(8). 1099–1108. 86 indexed citations
12.
Liu, Yijing, Yiquan Ke, Lei Chen, et al.. (2015). All-trans retinoic acid impairs the vasculogenic mimicry formation ability of U87 stem-like cells through promoting differentiation. Molecular Medicine Reports. 12(1). 165–172. 14 indexed citations
13.
Du, Wenzhong, Feng Yan, Xiaofeng Wang, et al.. (2013). Curcumin Suppresses Malignant Glioma Cells Growth and Induces Apoptosis by Inhibition of SHH/GLI1 Signaling Pathway in Vitro and Vivo. CNS Neuroscience & Therapeutics. 19(12). 926–936. 79 indexed citations
14.
Li, Ruiyan, Lingchao Chen, Haiyan Zhang, et al.. (2013). MiR‐139 Inhibits Mcl‐1 Expression and Potentiates TMZ‐Induced Apoptosis in Glioma. CNS Neuroscience & Therapeutics. 19(7). 477–483. 72 indexed citations
15.
Sun, Xu, Dan Zhao, Yongli Li, et al.. (2013). Regulation of ASIC1 by Ca2+/calmodulin-dependent protein kinase II in human glioblastoma multiforme. Oncology Reports. 30(6). 2852–2858. 37 indexed citations
16.
Shi, Minghan, et al.. (2011). TP53 codon 72 polymorphism and glioma risk: A meta-analysis. Oncology Letters. 3(3). 599–606. 11 indexed citations
17.
Zhang, Junhe, Licheng Zhang, Meng Xu, et al.. (2011). Murine RANK Protein’s Inhibition of Bone Resorption. Journal of Craniofacial Surgery. 22(6). 2084–2089. 2 indexed citations
18.
Zhang, Xiaoyu, Hongbin Yang, Binsheng Gong, Chuanlu Jiang, & Lizhuang Yang. (2011). Combined gene expression and protein interaction analysis of dynamic modularity in glioma prognosis. Journal of Neuro-Oncology. 107(2). 281–288. 42 indexed citations
19.
Jiang, Chuanlu. (2008). Expression of G6PD Protein in Gliomas and its Correlation with Glioma Grades. 2 indexed citations
20.
Li, Xianfeng, Masakazu Miyajima, Chuanlu Jiang, & Hajime Arai. (2006). Expression of TGF-βs and TGF-β type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus. Neuroscience Letters. 413(2). 141–144. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026